Improved hemostasis in hemophilia mice by means of an engineered factor Va mutant-Reference-Cited by-同舟云学术

Improved hemostasis in hemophilia mice by means of an engineered factor Va mutant

Published:2014-03 Issue:3 Volume:12 Page:363-372
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

von Drygalski A.¹²,Cramer T. J.¹,Bhat V.¹²,Griffin J. H.¹²,Gale A. J.¹²,Mosnier L. O.¹²

Affiliation:

1. Department of Molecular and Experimental Medicine; The Scripps Research Institute; La Jolla CA USA

2. Division of Hematology/Oncology; Department of Medicine; University California San Diego; San Diego CA USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12489/fullpdf

Reference33 articles.

1. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII;Hoffman;Blood Coagul Fibrinolysis,1998

2. The regulation of the factor VII-dependent coagulation pathway: rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders;Veer;Semin Thromb Hemost,2000

3. A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study;Astermark;Blood,2007

4. Arthropathy in inhibitor patients: differences in the joint status;Hoots;Semin Hematol,2008

5. Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial;Paula;J Thromb Haemost,2012

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maladaptive lymphangiogenesis is associated with synovial iron accumulation and delayed clearance in factor VIII–deficient mice after induced hemarthrosis;Journal of Thrombosis and Haemostasis;2023-09

2. Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis;Thrombosis and Haemostasis;2023-03-13

3. Adeno-associated virus-mediated expression of activated factor V (FVa) for hemophilia phenotypic correction;Frontiers in Medicine;2022-08-05

4. An engineered activated factor V for the prevention and treatment of acute traumatic coagulopathy and bleeding in mice;Blood Advances;2022-02-03

5. Cerebral Cavernous Malformation: From Mechanism to Therapy;Circulation Research;2021-06-25